Abstract:Key points Spinal muscular atrophy (SMA) is a health‐ and life‐limiting neuromuscular disorder caused by a deficiency in survival motor neuron (SMN) protein. While historically considered a motor neuron disease, current understanding of SMA emphasizes its systemic nature, which requires addressing affected peripheral tissues such as skeletal muscle in particular. Chronic physical activity is beneficial for SMA patients, however the cellular and molecular mechanisms of exercise biology are largely undefined in SMA. After a single bout of exercise, canonical responses such as skeletal muscle AMPK, p38, and PGC‐1α activation were preserved in SMA‐like Smn 2B/− animals. Furthermore, molecules involved in SMN transcription were also altered following physical activity. Collectively, these changes were coincident with an increase in full‐length SMN transcription and corrective SMN pre‐mRNA splicing. Our study advances understanding of the exercise biology of SMA and highlights the AMPK‐p38‐PGC‐1α axis as a potential regulator of SMN expression in muscle. Chronic physical activity is safe and effective in spinal muscular atrophy (SMA) patients, however the underlying cellular events that drive physiological adaptations are undefined. We examined the effects of a single bout of exercise on molecular mechanisms associated with adaptive remodelling in the skeletal muscle of Smn 2B/− SMA‐like mice. Skeletal muscles were collected from healthy Smn 2B/+ mice and Smn 2B/− littermates at pre‐ [postnatal day (P) 9], early‐ (P13) and late‐symptomatic (P21) stages to characterize SMA disease progression. Muscles were also collected from Smn 2B/− animals exercised to fatigue on a motorized treadmill. Intracellular signalling and gene expression were examined using Western blotting, confocal immunofluorescence microscopy, real‐time quantitative polymerase chain reaction (PCR), and endpoint PCR assays. Basal skeletal muscle AMP‐activated protein kinase (AMPK) and p38 mitogen‐activated protein kinase (p38) expression and activity were not affected by SMA‐like conditions. Canonical exercise responses such as AMPK, p38, and peroxisome proliferator‐activated receptor γ coactivator‐1α (PGC‐1α) activation were observed following a bout of exercise in Smn 2B/− animals. Furthermore, molecules involved in survival motor neuron (SMN) transcription including protein kinase B (AKT) and extracellular signal‐regulated kinases (ERK)/ ETS‐like gene 1 (ELK), were altered following physical activity. Acute exercise was also able to mitigate aberrant proteolytic signalling in the skeletal muscle of Smn 2B/− mice. Collectively, these changes were coincident with an exercise‐evoked increase in full‐length SMN mRNA expression. This study advances our understanding of the exercise biology of SMA and highlights the AMPK‐p38‐PGC‐1α axis as a potential regulator of SMN expression alongside AKT and ERK/ELK signalling. This article is protected by copyright. All rights reserved

Blocking p62-dependent SMN degradation ameliorates spinal muscular atrophy disease phenotypes

ML372 blocks SMN ubiquitination and improves spinal muscular atrophy pathology in mice

A spinal muscular atrophy modifier implicates the SMN protein in SNARE complex assembly at neuromuscular synapses

Peripheral Smn Restoration is Essential for Long-Term Rescue of A Severe Spinal Muscular Atrophy Mouse Model

A high-throughput genome-wide RNAi screen identifies modifiers of survival motor neuron protein

Motor neuron cell-nonautonomous rescue of spinal muscular atrophy phenotypes in mild and severe transgenic mouse models.

Mechanisms of exercise‐induced survival motor neuron expression in the skeletal muscle of spinal muscular atrophy‐like mice

Pharmacokinetics, pharmacodynamics, and efficacy of a small-molecule SMN2 splicing modifier in mouse models of spinal muscular atrophy

Ubiquitination Insight from Spinal Muscular Atrophy-From Pathogenesis to Therapy: A Muscle Perspective

Drug screening with human SMN2 reporter identifies SMN protein stabilizers to correct SMA pathology

Activating ATF6 in spinal muscular atrophy promotes SMN expression and motor neuron survival through the IRE1α-XBP1 pathway

The Power of Human Protective Modifiers: PLS3 and CORO1C Unravel Impaired Endocytosis in Spinal Muscular Atrophy and Rescue SMA Phenotype

SMN protein is required throughout life to prevent spinal muscular atrophy disease progression

Restoring SMN Expression: An Overview of the Therapeutic Developments for the Treatment of Spinal Muscular Atrophy

Targeted-SMN insufficiency in Skeletal Muscle Stem Cells mediates non-cell autonomous loss of motor neurons at long term

Antisense oligonucleotides targeting the SMN2 promoter region enhance SMN2 expression in spinal muscular atrophy cell lines and mouse model

Dysregulation of Synaptogenesis Genes Antecedes Motor Neuron Pathology in Spinal Muscular Atrophy

Motor unit recovery following Smn restoration in mouse models of spinal muscular atrophy

Discovery, synthesis, and biological evaluation of novel SMN protein modulators

Neurocalcin Delta Suppression Protects against Spinal Muscular Atrophy in Humans and across Species by Restoring Impaired Endocytosis

Targeted-Deletion of a Tiny Sequence via Prime Editing to Restore SMN Expression